Dyspnea: Recent insights and innovations

Progress in Palliative Care

Volumn 19, Issue 5, 2011, Pages 219-221

  Rocker, Graeme ^a  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; OPIATE;

AWARENESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CONGESTIVE HEART FAILURE; DYSPNEA; EDITORIAL; EVIDENCE BASED MEDICINE; GOLD STANDARD; HUMAN; LUNG FUNCTION TEST; PAIN; PALLIATIVE THERAPY; PRACTICE GUIDELINE; RELIABILITY;

EID: 80053444958     PISSN: 09699260     EISSN: 1743291X     Source Type: Journal    
DOI: 10.1179/174329111X13147108047456     Document Type: Editorial

References (25)

1. Smith J, Albert P, Bertella E, Lester J, Jack S, Calverley P. Qualitative aspects of breathlessness in health and disease. Thorax 2009;64(8):713-8.
2. Abernethy AP, Wheeler JL. Total dyspnoea. Curr Opin Support Palliat Care 2008;2(2):110-3.
3. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 2009;167(1):53-60.
4. Horton R, Rocker G. Contemporary issues in refractory dyspnoea in advanced chronic obstructive pulmonary disease. Curr Opin Support Palliat Care 2010;4(2):56-62.
5. von Leupoldt A, Sommer T, Kegat S, Baumann HJ, Klose H, Dahme B, et al. Dyspnea and pain share emotion-related brain network. Neuroimage 2009;48(1):200-6.
6. Schon D, Dahme B, von Leupoldt A. Associations between the perception of dyspnea, pain, and negative affect. Psychophysiology 2008;45(6):1064-7.
7. Bausewein C, Booth S, Higginson IJ. Measurement of dyspnoea in the clinical rather than the research setting. Curr Opin Support Palliat Care 2008;2(2):95-9.
8. Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010;65(1):21-6.
9. Simpson C. When hope makes us vulnerable: a discussion of patient-healthcare provider interactions in the context of hope. Bioethics 2004;18(5):428-47.
10. Sinuff T. Noninvasive positive pressure ventilation for acute respiratory failure: What role is there for patients declining intubation or choosing palliation? Prog Palliat Care 2011;19(5):223-9.
11. Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, et al. for the Canadian Thoracic Society COPD Committee Dyspnea Expert Working Group. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J 2011;18(2):1-10.
12. Robinson WM. A symptom-based approach to palliative care in cystic fibrosis. Prog Palliat Care 2011;19(5):230-4.
13. Maraveyas A, Johnson M. Anti-cancer agent-induced dyspnea. Prog Palliat Care 2011;19(5):235-42.
14. Simpson AC. An opportunity to care? Preliminary insights from a qualitative study on advance care planning in advanced COPD. Prog Palliat Care 2011;19(5):243-53.
15. Booth S, Bausewein C, Rocker G. New models of care for advanced lung disease. Prog Palliat Care 2011;19(5):254-63.
16. Peiffer C. Dyspnea and emotion:what canwe learn fromfunctional brain imaging?. Am J Respir Crit Care Med 2008;177(9):937-9.
17. Guyatt G, Sackett D, Adachi J, Roberts R, Chong J, Rosenbloom D, et al. A clinician's guide for conducting randomized trials in individual patients. Can Med Assoc J 1988;139(6):497-503.
18. Smith TJ, Coyne P, French W, Ramakrishnan V, Corrigan P. Failure to accrue to a study of nebulized fentanyl for dyspnea: lessons learned. J Palliat Med 2009;12(9):771-2.
19. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002;57(11):939-44.
20. Abernethy AP, Aziz NM, Basch E, Bull J, Cleeland CS, Currow DC, et al. A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med. 2010;13(12):1407-13.
21. Abernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE, 2nd, Marcello J, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet 2010; 376(9743):784-93.
22. Maltais F, Bourbeau J, Shapiro S, Lacasse Y, Perrault H, Baltzan M, et al. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2008;149(12):869-78.
23. Rabinovich RA, Vilaro J. Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2010;16(2):123-33.
24. Currow DC, McDonald C, Oaten S, Kenny B, Allcroft P, Frith P, et al. Once-Daily Opioids for Chronic Dyspnea: a Dose Increment and Pharmacovigilance Study. Journal [Internet]. 2011, Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21458217.
25. Epstein RM, Fiscella K, Lesser CS, Stange KC. Why the nation needs a policy push on patient-centered health care. Health Aff (Millwood) 2010;29(8):1489-95.